Book and Media Reviews Section Editor: John L. Zeller, MD, PhD.
First identified and named by William Dameshek in 1951, myeloproliferative disorders have become “landmarks in the history of malignant disease . . . on which progress in understanding and treating other malignancies . . . and indeed solid tumors can be based.” Despite their relative infrequency in ordinary clinical practice, they are not uncommon in hematologic practice. From that perspective, the contributors do not regard this new book to be targeted to any particular audience but that it “should be of interest to medical students who find the specialty of hematology truly fascinating.” For other physicians and for patients, this reference provides a needed understanding of avant-garde medical research.
Wehrmacher WH, Messmore HL. Myeloproliferative Disorders (Hematologic Malignancies). JAMA. 2007;298(3):339–343. doi:10.1001/jama.298.3.343
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: